Article
AKT in cancer: new molecular insights and advances in drug development
27 May 2016
Abstract excerpt
The phosphatidylinositol-3 kinase (PI3K)-AKT pathway is one of the most commonly dysregulated pathways in all of cancer, with somatic mutations, copy number alterations, aberrant epigenetic regulation and increased expression in a number of cancers. The carefully maintained homeostatic balance of cell division and growth on one hand, and programmed cell death on the other, is universally disturbed in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
